Life Sciences Tools & Services Companies By Ebitda

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
EBITDA
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
EBITDAEfficiencyMarket RiskExp Return
1TMO Thermo Fisher Scientific
11.54 B
(0.01)
 1.55 
(0.01)
2IQV IQVIA Holdings
3.45 B
(0.09)
 1.61 
(0.15)
3ICLR ICON PLC
1.59 B
(0.11)
 2.08 
(0.23)
4A Agilent Technologies
1.49 B
(0.11)
 1.64 
(0.19)
5MTD Mettler Toledo International
1.24 B
(0.03)
 1.61 
(0.05)
6AVTR Avantor
1.08 B
(0.14)
 2.78 
(0.40)
7WAT Waters
1.04 B
 0.00 
 1.83 
 0.00 
8RVTY Revvity
848.01 M
(0.02)
 2.02 
(0.04)
9QGEN Qiagen NV
702.07 M
(0.13)
 1.52 
(0.19)
10CRL Charles River Laboratories
581.14 M
(0.09)
 2.36 
(0.22)
11MEDP Medpace Holdings
446.87 M
(0.04)
 1.99 
(0.08)
12SHC Sotera Health Co
442.2 M
(0.08)
 2.22 
(0.18)
13TECH Bio Techne Corp
310.37 M
(0.13)
 2.18 
(0.29)
14CDT Conduit Pharmaceuticals
266.46 M
(0.16)
 16.64 
(2.60)
15BRKR Bruker
253.1 M
(0.18)
 2.59 
(0.46)
16RGEN Repligen
113.34 M
(0.01)
 3.18 
(0.03)
17AZTA Azenta Inc
21.8 M
(0.21)
 2.83 
(0.60)
18HBIO Harvard Bioscience
(1.3 M)
(0.43)
 4.37 
(1.90)
19CSBR Champions Oncology
(5.05 M)
 0.05 
 5.46 
 0.28 
20CGEN Compugen
(14.4 M)
 0.03 
 4.84 
 0.13 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital. In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY